SIR for new primary cancers according to year of follow-up for patients with ET, PV, or CML. ○ indicates ET with hematologic cancer; ♢, ET with nonhematologic cancer; Δ, PV with hematologic cancer; +, PV with nonhematologic cancer; ×, CML with hematologic cancer; and □, CML with nonhematologic cancer.